🇺🇸 FDA
Pipeline program

Bu-Yang-Huan-Wu Tang

CMUH102-REC1-122

Phase 2 small_molecule active

Quick answer

Bu-Yang-Huan-Wu Tang for Ischemic Stroke is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Ischemic Stroke
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials